Home
Conditions
Lymphoma

Clinical trial condition

Lymphoma

Explore clinical trials studying Lymphoma. Study availability and eligibility vary by location and protocol.

2,141 public trials 305 recruiting studies

Refine in advanced search Browse all conditions

Lymphoma trial results

Completed

Efficacy of Lenalidomide With Rituximab in Refractory or Relapse of Primary Central Nervous System Lymphoma

NCT01956695

Conditions: Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +10 more
Locations: Centre Léon Bérard Lyon, Auvergne-Rhône-Alpes, France

CHU Estaing Clermont-Ferrand, Auvergne, France

CHU Bretonneau - Centre Henry Kaplan Tours, Centre-Val de Loire, France

Institut Bergonié Bordeaux, Gironde, France

View Trial Details

Completed

Donor Stem Cell Transplant in Treating Patients With Previously Treated Lymphoma, Multiple Myeloma, or Chronic Lymphocytic Leukemia

NCT00612716

Conditions: Blood Protein Disorders, Burkitt Lymphoma, Cardiovascular Diseases, +47 more
Locations: Masonic Cancer Center, University of Minnesota Minneapolis, Minnesota, United States

View Trial Details

Completed

tTF-NGR Phase I Study

NCT02902237

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations: University Hospital Muenster Münster, North Rhine-Westphalia, Germany

View Trial Details

Completed

Modified Hyper-CVAD (Cyclophosphamide, Vincristine, Adriamycin, and Dexamethasone) Program for Acute Lymphoblastic Leukemia

NCT00671658

Conditions: Acute Lymphoblastic Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +10 more
Locations: UT MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Lenalidomide in Treating Patients With Relapsed Mycosis Fungoides/Sezary Syndrome

NCT00466921

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +10 more
Locations: Stanford Cancer Center Stanford, California, United States

Robert H. Lurie Comprehensive Cancer Center at Northwestern University Chicago, Illinois, United States

M. D. Anderson Cancer Center at University of Texas Houston, Texas, United States

View Trial Details

Completed

Study of Lymphoma in Asia

NCT01584141

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Hodgkin Disease, +13 more
Locations: Tianjin Medical University Cancer Institute & Hospital Hexi District, China

West China Hospital of Sichuan University Sichuan, China

Queen Mary Hospital Sai Ying Pun, Hong Kong

Buddhis Dalin Tzu Chi General Hospital Dalin Town, Taiwan

View Trial Details

Completed

IACS-010759 in Advanced Cancers

NCT03291938

Conditions: Advanced Malignant Solid Neoplasm, Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, +46 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Non-Myeloablative Conditioning for Unrelated Donor Umbilical Cord Blood Transplant

NCT00305682

Conditions: Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +10 more
Locations: Masonic Cancer Center at University of Minnesota Minneapolis, Minnesota, United States

View Trial Details

Completed

Fludarabine, Mitoxantrone, and Dexamethasone (FND) Plus Rituximab for Lymphoma Patients

NCT00577993

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations: University of Texas MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Rituximab and Combination Chemotherapy Combined With Yttrium Y 90 Ibritumomab Tiuxetan in Treating Older Patients With Previously Untreated B-Cell Lymphoma

NCT00058422

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations: Memorial Sloan Kettering Cancer Center New York, United States

M. D. Anderson Cancer Center at University of Texas Houston, Texas, United States

View Trial Details

Lymphoma

Lymphoma trial results

Related conditions